R Ceska Selected Research

Pharmavit

6/2000

[Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R Ceska Research Topics

Disease

12	Atherosclerosis 01/2008 - 01/2000
9	Hyperlipidemias (Hyperlipidemia) 08/2011 - 06/2000
7	Dyslipidemias (Dyslipidemia) 03/2011 - 01/2007
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2011 - 04/2007
6	Hypercholesterolemia 01/2008 - 06/2000
5	Cardiovascular Diseases (Cardiovascular Disease) 07/2010 - 05/2000
4	Coronary Disease (Coronary Heart Disease) 05/2010 - 01/2001
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2008 - 11/2000
4	Hyperlipoproteinemias 01/2003 - 03/2000
3	Diabetes Mellitus 03/2011 - 06/2000
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 01/2000
2	Weight Loss (Weight Reduction) 09/2012 - 03/2011
2	Body Weight (Weight, Body) 03/2011 - 04/2007
2	Metabolic Diseases (Metabolic Disease) 03/2011 - 06/2010
2	Hypertension (High Blood Pressure) 08/2010 - 06/2000
2	Inflammation (Inflammations) 01/2009 - 11/2001
2	Overweight 08/2003 - 01/2001
2	Vascular Diseases (Vascular Disease) 01/2003 - 01/2002
1	Rhabdomyolysis 01/2014
1	Muscular Diseases (Myopathy) 01/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2014
1	Myalgia 01/2014
1	Abdominal Obesity 03/2011
1	Obesity 03/2011
1	Exanthema (Rash) 05/2010
1	Flushing 05/2010
1	Pruritus (Itching) 05/2010
1	Type 2 Diabetes Mellitus (MODY) 01/2009
1	Hyperlipoproteinemia Type III (Broad Beta Disease) 01/2003
1	Insulin Resistance 11/2001
1	Hypertriglyceridemia 01/2001
1	Acute Coronary Syndrome 01/2001
1	Lipid Metabolism Disorders (Metabolism Disorders, Lipid) 12/2000
1	Atherosclerotic Plaque (Atheroma) 12/2000

Drug/Important Bio-Agent (IBA)

14	LipidsIBA 08/2011 - 01/2000
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 04/2007
7	HDL CholesterolIBA 03/2011 - 06/2000
7	LDL CholesterolIBA 07/2010 - 01/2000
7	CholesterolIBA 05/2010 - 05/2000
6	Triglycerides (Triacylglycerol)IBA 09/2012 - 01/2001
5	Atorvastatin (Lipitor)FDA Link 08/2011 - 11/2001
5	ApolipoproteinsIBA 01/2008 - 01/2000
4	oxidized low density lipoproteinIBA 07/2010 - 01/2008
4	Lipoprotein(a)IBA 01/2008 - 06/2000
4	Fenofibrate (CiL)FDA LinkGeneric 04/2007 - 06/2000
4	Apolipoproteins E (ApoE)IBA 01/2003 - 01/2000
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2008
3	Lipoproteins (Lipoprotein)IBA 06/2010 - 06/2000
3	Cell Adhesion MoleculesIBA 01/2008 - 01/2001
2	ThiazolidinedionesIBA 03/2011 - 01/2009
2	Metformin (Glucophage)FDA LinkGeneric 03/2011 - 01/2009
2	Apoprotein(a) (Apolipoprotein (a))IBA 01/2008 - 01/2000
2	SelectinsIBA 08/2003 - 01/2001
2	Apolipoprotein B-100 (Apo B 100)IBA 01/2001 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 01/2001 - 12/2000
2	Cytidine Monophosphate (CMP)IBA 09/2000 - 06/2000
1	IncretinsIBA 03/2011
1	Hypoglycemic Agents (Hypoglycemics)IBA 03/2011
1	DiureticsIBA 08/2010
1	Telmisartan (Micardis)FDA Link 08/2010
1	Chymosin (Rennin)IBA 08/2010
1	AngiotensinsIBA 08/2010
1	Calcium Channels (Calcium Channel)IBA 08/2010
1	Antihypertensive Agents (Antihypertensives)IBA 08/2010
1	ProstaglandinsIBA 05/2010
1	Niacin (Nicotinic Acid)FDA LinkGeneric 05/2010
1	Glucose (Dextrose)FDA LinkGeneric 05/2010
1	Transaminases (Aminotransferases)IBA 05/2010
1	Prostaglandins DIBA 05/2010
1	Rosiglitazone (Avandia)FDA Link 01/2009
1	Indicators and Reagents (Reagents)IBA 05/2008
1	Oxidoreductases (Dehydrogenase)IBA 01/2008
1	Cholesterol 7-alpha-Hydroxylase (Cholesterol 7 alpha Hydroxylase)IBA 01/2008
1	Apolipoproteins AIBA 01/2008
1	CytochromesIBA 01/2008
1	Coenzyme A (CoA)IBA 01/2008
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2008
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2008
1	Fibric Acids (Fibrates)IBA 04/2007
1	Matrix Metalloproteinases (MMPs)IBA 09/2005
1	Testosterone (Sustanon)FDA Link 01/2005
1	Dehydroepiandrosterone (DHEA)IBA 01/2005
1	Sulfates (Sulfates, Inorganic)IBA 01/2005
1	SteroidsIBA 01/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2005
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2005
1	Orosomucoid (Seromucoid)IBA 08/2003
1	Transferrin (beta 2 Transferrin)IBA 08/2003
1	Fibrinogen (Factor I)FDA Link 08/2003
1	Plasminogen Activator Inhibitor 1IBA 08/2003
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 08/2003
1	Biomarkers (Surrogate Marker)IBA 01/2002
1	HomocysteineIBA 09/2001
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2001
1	PlasminogenIBA 12/2000

Therapy/Procedure

10	Therapeutics 04/2007 - 01/2001
2	Secondary Prevention 05/2008 - 01/2001
1	Bariatric Surgery 03/2011
1	Drug Therapy (Chemotherapy) 03/2011
1	Transcutaneous Electric Nerve Stimulation (TENS) 03/2011